Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.

Karski EE, Matthay KK, Neuhaus JM, Goldsby RE, Dubois SG.

Cancer Epidemiol. 2013 Feb;37(1):29-33. doi: 10.1016/j.canep.2012.08.006. Epub 2012 Sep 5.

2.

Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ.

J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.

PMID:
21184634
3.

Clinical features and outcomes in patients with secondary Ewing sarcoma.

Applebaum MA, Goldsby R, Neuhaus J, DuBois SG.

Pediatr Blood Cancer. 2013 Apr;60(4):611-5. doi: 10.1002/pbc.24251. Epub 2012 Jul 27.

4.

Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.

Wong T, Goldsby RE, Wustrack R, Cash T, Isakoff MS, DuBois SG.

Pediatr Blood Cancer. 2015 Nov;62(11):1947-51. doi: 10.1002/pbc.25635. Epub 2015 Jul 14.

PMID:
26173989
5.

Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.

Davenport JR, Vo KT, Goldsby R, West DC, DuBois SG.

Pediatr Blood Cancer. 2016 Jun;63(6):1091-5. doi: 10.1002/pbc.25945. Epub 2016 Feb 17.

PMID:
26891183
6.

Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.

Arshi A, Sharim J, Park DY, Park HY, Yazdanshenas H, Bernthal NM, Shamie AN.

Spine J. 2017 May;17(5):645-655. doi: 10.1016/j.spinee.2016.11.002. Epub 2016 Nov 14.

PMID:
27856382
7.

Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

Applebaum MA, Goldsby R, Neuhaus J, DuBois SG.

Pediatr Blood Cancer. 2012 Oct;59(4):617-20. doi: 10.1002/pbc.24053. Epub 2011 Dec 19.

8.

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.

Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC, Dubois SG.

Cancer. 2011 Jul 1;117(13):3027-32. doi: 10.1002/cncr.25840. Epub 2011 Jan 10.

9.

Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.

Schneiderman BA, Kliethermes SA, Nystrom LM.

Clin Orthop Relat Res. 2017 Mar;475(3):799-805. doi: 10.1007/s11999-016-4779-2.

10.

Adverse impact of regional lymph node involvement in osteosarcoma.

Thampi S, Matthay KK, Goldsby R, DuBois SG.

Eur J Cancer. 2013 Nov;49(16):3471-6. doi: 10.1016/j.ejca.2013.06.023. Epub 2013 Jul 15.

PMID:
23867123
11.

Ewing Sarcoma of the Head and Neck.

Ellis MA, Gerry DR, Neskey DM, Lentsch EJ.

Ann Otol Rhinol Laryngol. 2017 Mar;126(3):179-184. doi: 10.1177/0003489416681322. Epub 2017 Jan 5.

PMID:
28056517
12.

Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.

Friedman DN, Chastain K, Chou JF, Moskowitz CS, Adsuar R, Wexler LH, Chou AJ, DeRosa A, Candela J, Magnan H, Pun S, Kahan T, Wolden SL, Meyers PA, Oeffinger KC.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26562. Epub 2017 Apr 18.

PMID:
28417551
13.

Ethnic and racial differences in patients with Ewing sarcoma.

Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG.

Cancer. 2010 Feb 15;116(4):983-8. doi: 10.1002/cncr.24865.

14.

Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005.

Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP.

Cancer. 2009 Aug 1;115(15):3526-36. doi: 10.1002/cncr.24388.

15.

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

Paulussen M, Ahrens S, Burdach S, Craft A, Dockhorn-Dworniczak B, Dunst J, Fröhlich B, Winkelmann W, Zoubek A, Jürgens H.

Ann Oncol. 1998 Mar;9(3):275-81.

PMID:
9602261
16.

Surgery significantly improves survival in patients with chordoma.

Jawad MU, Scully SP.

Spine (Phila Pa 1976). 2010 Jan 1;35(1):117-23. doi: 10.1097/BRS.0b013e3181b44387.

PMID:
20042964
17.

A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.

Tural D, Selçukbiricik F, Serdengeçti S, Büyükünal E.

World J Surg Oncol. 2012 Nov 2;10:234. doi: 10.1186/1477-7819-10-234.

18.

Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyers PA, Felgenhauer J, Marina N, DuBois SG.

Pediatr Blood Cancer. 2016 Jan;63(1):47-53. doi: 10.1002/pbc.25709. Epub 2015 Aug 10.

19.

Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group.

Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, DuBois SG.

Pediatr Blood Cancer. 2016 Oct;63(10):1771-9. doi: 10.1002/pbc.26096. Epub 2016 Jun 14.

20.

Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies.

Hense HW, Ahrens S, Paulussen M, Lehnert M, Jürgens H.

Ann Oncol. 1999 Sep;10(9):1073-7.

PMID:
10572605

Supplemental Content

Support Center